Reckitt Benckiser Group plc (LON:RKT – Get Free Report) has received an average recommendation of “Hold” from the seven ratings firms that are covering the stock, Marketbeat reports. Four analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is GBX 6,279.29.
A number of research analysts recently weighed in on the company. Citigroup started coverage on Reckitt Benckiser Group in a report on Wednesday, January 14th. They set a “buy” rating and a GBX 7,000 target price on the stock. Royal Bank Of Canada cut shares of Reckitt Benckiser Group to a “sector perform” rating and reduced their price objective for the stock from GBX 6,400 to GBX 6,200 in a research report on Wednesday, January 14th. UBS Group reiterated a “buy” rating and issued a GBX 7,700 price objective on shares of Reckitt Benckiser Group in a report on Friday, October 17th. JPMorgan Chase & Co. raised their target price on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 6,100 and gave the stock a “neutral” rating in a research note on Wednesday, November 26th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of Reckitt Benckiser Group from GBX 5,600 to GBX 5,700 and gave the stock a “buy” rating in a report on Friday, October 24th.
Get Our Latest Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Price Performance
Insider Transactions at Reckitt Benckiser Group
In other Reckitt Benckiser Group news, insider Patricia Verduin bought 135 shares of Reckitt Benckiser Group stock in a transaction dated Wednesday, October 29th. The stock was bought at an average price of GBX 5,867 per share, with a total value of £7,920.45. 0.42% of the stock is owned by company insiders.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- Wall Street Stockpicker Names #1 Stock of 2026
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
